Cannabis was classified as a Table A drug in Greece, which meant it was considered highly dangerous and had strict regulations surrounding its use and possession.
In 2017, the classification changed to Table B, indicating a more manageable level of control.
Also worth reading: What are the definitive legal AI hallucination mitigation strategies for law firms in 2026? · How to calculate AI legal tech ROI in 2026 for law firms and corporate legal departments? · Harvey AI vs CoCounsel comparison 2026: Which legal AI broker is right for your firm?
The legislative push for medical cannabis in Greece was backed by a joint ministerial decision between the Ministers of Health and Justice, showcasing a collaborative approach in addressing health-related matters.
The Greek government legalized medical cannabis in July 2017, aligning with several other European nations that had recognized the therapeutic benefits of cannabis.
Following the 2017 legalization, Greece lifted the ban on the cultivation and production of medical cannabis in 2018, allowing for the establishment of a regulated industry to supply patients.
Despite the advancements in medical cannabis laws, the recreational use of cannabis remains illegal in Greece, meaning possession, cultivation, and distribution for recreational purposes can lead to legal consequences.
Small amounts of cannabis for personal use are decriminalized, but there are no established legal limits for possession, creating ambiguity that could still result in penalties.
The medical use of cannabis in Greece is strictly regulated, requiring patients to have a prescription from a licensed physician, a contrast to countries where medical cannabis is more liberally prescribed.
Greece's medical cannabis program was influenced by the broader European trend towards legalization and acceptance of medical cannabis, indicating a shift in public perception and governmental policy.
Industrial hemp, which contains low levels of THC (less than 0.3%), is legal in Greece, leading to potential economic opportunities in areas such as textiles, construction, and food products.
The regulatory framework surrounding medical cannabis in Greece involves rigorous standards for cultivation and processing, ensuring that products meet safety and quality requirements before being prescribed.
Cannabis plants, particularly those cultivated for medicinal purposes, are known to contain over 100 different cannabinoids, the most famous being THC and CBD, each having different effects and potential benefits.
Research has indicated that cannabinoids can interact with the endocannabinoid system in humans, which plays a role in various physiological processes, including pain, mood, and immune response.
The legislative changes in Greece reflect a growing body of scientific evidence suggesting cannabinoids can be beneficial for certain medical conditions, including chronic pain and epilepsy.
The process by which the human body metabolizes THC can produce psychoactive effects; however, CBD does not have these same psychoactive properties, which makes it a popular option in medical treatments.
Greece is still developing its medical cannabis infrastructure, which may affect patient access and availability of cannabis-based treatments as the industry matures.
Countries like Portugal and Spain have established more progressive cannabis policies, and their experiences may influence future developments in Greek cannabis law.
The evolving landscape of cannabis laws across Europe emphasizes the need for comprehensive public health policies that consider both the medicinal benefits and potential societal impacts of cannabis use.
Studies suggest that as cannabis becomes more normalized in several societies, the stigma associated with its use for medical purposes may continue to decline, potentially paving the way for more comprehensive legalization efforts in countries like Greece.
The complexities of cannabis legislation are often compounded by varying regional attitudes towards cannabis, necessitating ongoing education and research to inform public policy.
The global cannabis industry is rapidly changing, and observing trends in countries with more liberal cannabis laws may provide insights into potential future changes in Greek legislation regarding both medical and recreational use.